{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:33:12Z","timestamp":1794375192100,"version":"4.9.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer is the most common malignant tumor among women globally. While traditional treatments are effective, they are associated with numerous side effects. In recent years, traditional Chinese herbal decoctions have garnered attention as adjunctive therapeutic approaches. This study employs a network meta-analysis to evaluate the efficacy and safety of various Chinese herbal decoctions in breast cancer treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was conducted across PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wan fang, and VIP databases for randomized controlled trials comparing the efficacy and safety of different Chinese herbal decoctions in breast cancer patients, up to 20 December 2025. Quality assessment was performed using the Risk of Bias 2.0 tool. Network meta-analysis was conducted using R 4.5.1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 68 articles involving 4,708 patients were included, meta-analysis results suggest that compared with the control group, for objective response rate YHHYT [OR\u00a0=\u00a04.76, 95%CrI (1.25, 25)] ranked first in cumulative probability (81.42%). Regarding disease control rate, BZT demonstrated an [OR\u00a0=\u00a05.77, 95%CrI (1.59, 29)] and ranked first in cumulative probability (74.66%). For CD4+\/CD8+, FJHQT [MD= MD\u00a0=\u00a00.69, 95%CrI (0.2, 1.17)] achieved an 88.00% cumulative probability ranking, finally, regarding nausea and vomiting relief BZT [OR\u00a0=\u00a00.25, 95%CrI (0.1, 0.57)] ranked first in cumulative probability (75.67%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study employed a network meta-analysis to evaluate the efficacy of multiple Chinese herbal decoctions in breast cancer treatment. Results demonstrated that these decoctions exhibited significant therapeutic effects in enhancing target response rates, disease control rates, and immune function (CD4+\/CD8+ ratio) among breast cancer patients, while also alleviating chemotherapy side effects such as nausea and vomiting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420261279914<\/jats:ext-link>\n                      , identifier CRD420261279914.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1785268","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:52:11Z","timestamp":1783486331000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of traditional Chinese medicine decoctions in breast cancer treatment: a network meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Haidi","family":"Han","sequence":"first","affiliation":[{"name":"Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Du","sequence":"additional","affiliation":[{"name":"Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juncai","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjing","family":"Dong","sequence":"additional","affiliation":[{"name":"Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixia","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Second Medical University","place":["Weifang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41392-025-02401-w","article-title":"Diabetes and its complications: molecular mechanisms, prevention and treatment","volume":"11","author":"Zhao","year":"2026","journal-title":"Signal Transduct Target Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41574-025-01171-3","article-title":"Mechanisms of diabetic kidney disease and established and emerging treatments","volume":"22","author":"Martinez Leon","year":"2026","journal-title":"Nat Rev Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2025.09.023","article-title":"New potential therapeutic targets of metabolic disorder-associated kidney disease and diabetic kidney disease","volume":"109","author":"Li","year":"2026","journal-title":"Kidney Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.112737","article-title":"Macrophages in Focus: Key Drivers and Therapeutic Opportunities in Diabetic Kidney Disease","volume":"21","author":"Zhao","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/s41419-024-06833-0","article-title":"Mitochondrial metabolic reprogramming in diabetic kidney disease","volume":"15","author":"Fan","year":"2024","journal-title":"Cell Death Dis"},{"key":"B6","first-page":"Cd006257","article-title":"Angiotensin-converting-enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic kidney disease","volume":"4","author":"Natale","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-024-00827-z","article-title":"Combination therapy for kidney disease in people with diabetes mellitus","volume":"20","author":"van Raalte","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-025-01042-0","article-title":"Next-generation therapeutics for diabetic kidney disease","author":"Yi","year":"2026","journal-title":"Nat Rev Nephrol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.70059","article-title":"Targeting Mitochondrial Dysfunction by Natural Products for the Treatment of Diabetic Kidney Disease","volume":"39","author":"Huo","year":"2025","journal-title":"Phytother Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2024.2351946","article-title":"Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota","volume":"62","author":"Wu","year":"2024","journal-title":"Pharm Biol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2024.2314705","article-title":"Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment","volume":"62","author":"Shen","year":"2024","journal-title":"Pharm Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X22500744","article-title":"A Review of Traditional Chinese Medicine on Treatment of Diabetic Nephropathy and the Involved Mechanisms","volume":"50","author":"Liu","year":"2022","journal-title":"Am J Chin Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"115952","DOI":"10.1016\/j.biopha.2023.115952","article-title":"Ferroptosis: A new view on the prevention and treatment of diabetic kidney disease with traditional Chinese medicine","volume":"170","author":"Chen","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1142\/S0192415X25500260","article-title":"Traditional Chinese Medicine Formulae and Chinese Patent Medicines for the Treatment of Diabetic Kidney Disease: Efficacies and Mechanisms","volume":"53","author":"Li","year":"2025","journal-title":"Am J Chin Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1631312","DOI":"10.3389\/fendo.2025.1631312","article-title":"Research progress in the treatment of lipid metabolism disorder in patients with diabetic kidney disease by the integrated traditional Chinese and Western medicine","volume":"16","author":"Sheng","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1568438","DOI":"10.3389\/fendo.2025.1568438","article-title":"Impact of finerenone on chronic kidney disease progression in Chinese patients with type 2 diabetes: a FIGARO-DKD subgroup analysis","volume":"16","author":"Li","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"154079","DOI":"10.1016\/j.phymed.2022.154079","article-title":"Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: A multicenter, randomized controlled trial","volume":"100","author":"Liu","year":"2022","journal-title":"Phytomedicine"},{"key":"B18","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B19","doi-asserted-by":"publisher","first-page":"102433","DOI":"10.1016\/j.ctim.2020.102433","article-title":"The reporting quality and risk of bias of randomized controlled trials of acupuncture for migraine: Methodological study based on STRICTA and RoB 2.0","volume":"52","author":"Lu","year":"2020","journal-title":"Complement Ther Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"Bmj"},{"key":"B21","article-title":"Analysis of Treatment of Diabetic Kidney Disease with Modified Buyang Huanwutang Based on 5hmC-Seal Sequencing Technology","volume":"31","author":"Zhen","year":"2025","journal-title":"Chin J Exp Traditional Med Formulae"},{"key":"B22","doi-asserted-by":"publisher","first-page":"119357","DOI":"10.1016\/j.jep.2025.119357","article-title":"Danggui Buxue decoction regulates autophagy to Improve renal fibrosis in diabetes through miR-27a \/PI3K\/AKT pathway","volume":"341","author":"Wang","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"119478","DOI":"10.1016\/j.jep.2025.119478","article-title":"Modulating HIF-1\u03b1\/HIF-2\u03b1 homeostasis with Shen-Qi-Huo-Xue formula alleviates tubular ferroptosis and epithelial-mesenchymal transition in diabetic kidney disease","volume":"343","author":"Yang","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B24","article-title":"Clinical observation on effect of Yiqi Yangyin Huoxue Tongfu principle in treating diabetes mellitus type 2 of secondary failure to sulfonylurea agents","volume":"24","author":"Chen","year":"2004","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"B25","article-title":"Study of prevention and treatment on acute radioactive","author":"Wang","year":""},{"key":"B26","doi-asserted-by":"publisher","first-page":"8391854","DOI":"10.1155\/2020\/8391854","article-title":"Yiqi Yangyin Huoxue Method in Treating IdiopathicPulmonary Fibrosis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","volume":"2020","author":"Zhou","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7150\/thno.123141","article-title":"Pharmacologically inherited carbon dots from Salvia miltiorrhiza with potent antioxidant activity and multi-pathway modulation for myocardial ischemia-reperfusion injury therapy","volume":"16","author":"Zhang","year":"2026","journal-title":"Theranostics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"155916","DOI":"10.1016\/j.phymed.2024.155916","article-title":"Jiawei Taohe Chengqi Decoction attenuates CCl(4) induced hepatic fibrosis by inhibiting HSCs activation via TGF-\u03b21\/CUGBP1 and IFN-\u03b3\/Smad7 pathway","volume":"133","author":"Ye","year":"2024","journal-title":"Phytomedicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"116059","DOI":"10.1016\/j.jep.2022.116059","article-title":"Jiawei Taohe Chengqi Decoction attenuates hepatic fibrosis by preventing activation of HSCs through regulating Src\/ERK\/Smad3 signal pathway","volume":"305","author":"Huang","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"117486","DOI":"10.1016\/j.jep.2023.117486","article-title":"Jiawei Taohe Chengqi decoction inhibition of the notch signal pathway affects macrophage reprogramming to inhibit HSCs activation for the treatment of hepatic fibrosis","volume":"321","author":"Shao","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"936853","DOI":"10.3389\/fphar.2022.936853","article-title":"Tongluo Yishen Decoction Ameliorates Renal Fibrosis via NLRP3-Mediated Pyroptosis In Vivo and In Vitro","volume":"13","author":"Jia","year":"2022","journal-title":"Front Pharmacol"},{"key":"B32","article-title":"To evaluate the efficacy of Yishen Tongluo decoction combined with low-dose tadalafil in the treatment of diabetic erectile dysfunction with kidney deficiency and blood stasis syndrome","volume":"29","author":"Wu","year":"2023","journal-title":"Zhonghua Nan Ke Xue"},{"key":"B33","doi-asserted-by":"publisher","first-page":"154988","DOI":"10.1016\/j.phymed.2023.154988","article-title":"Exploring the possible mechanism(s) underlying the nephroprotective effect of Zhenwu Decoction in diabetic kidney disease: An integrated analysis","volume":"119","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"B34","doi-asserted-by":"publisher","first-page":"155694","DOI":"10.1016\/j.phymed.2024.155694","article-title":"Modified Zhenwu Decoction suppresses chronic colitis via targeting macrophage CCR2\/Fyn\/p38 MAPK signaling axis","volume":"129","author":"Mok","year":"2024","journal-title":"Phytomedicine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2013.11.028","article-title":"Clinical trials of traditional Chinese medicine in the treatment of diabetic nephropathy\u2013a systematic review based on a subgroup analysis","volume":"151","author":"Liu","year":"2014","journal-title":"J Ethnopharmacol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"106111","DOI":"10.1016\/j.phrs.2022.106111","article-title":"Comparative effectiveness of traditional Chinese medicine and angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and sodium glucose cotransporter inhibitors in patients with diabetic kidney disease: A systematic review and network meta-analysis","volume":"177","author":"Zhang","year":"2022","journal-title":"Pharmacol Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1785268\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:52:26Z","timestamp":1783486346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1785268\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":36,"alternative-id":["10.3389\/fonc.2026.1785268"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1785268","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fonc.2026.1785268.s001","asserted-by":"subject"}]},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"1785268"}}